Immunoreactive peptides from epstein-barr virus

Details Immunoreactive peptides from epstein-barr virus Immunoreactive peptides from epstein-barr virus

C - Chemistry, Metallurgy

12

N

C12N 15/38 (2006.01) A61K 39/245 (2006.01) A61P 31/22 (2006.01) C07K 7/08 (2006.01) C07K 14/05 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2143642

Epstein-Barr virus (EBV) specific polypeptides are disclosed. Also disclosed are the use of these polypeptides for the production of polypeptide-specific antibodies and the diagnosis and treatment of EBV-associated disease.

Affiliated with

Also associated with

Rating

Immunoreactive peptides from epstein-barr virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoreactive peptides from epstein-barr virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoreactive peptides from epstein-barr virus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2015402